Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 3/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.42 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.41 |
| ▸ | AGXT | P21549 | 3/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | BAD | Q92934 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131868 | 0.92 | — | — | |
| SCHEMBL27493237 | 0.89 | IDO1 (0.50) | MAOBIDO1LOXL2TAAR1AGXT | |
| SCHEMBL27841176 | 0.82 | IDO1 (0.44) | MAOBIDO1LOXL2TAAR1AGXT | |
| SCHEMBL6626055 | 0.80 | MAOB (0.59) | MAOBIDO1LOXL2TAAR1PYCR1 | |
| SCHEMBL9106789 | 0.78 | LTA4H (0.46) | MAOBIDO1LOXL2AGXT | |
| SCHEMBL27882665 | 0.78 | TAAR1 (0.69) | TAAR1AGXTPTPN1 | |
| SCHEMBL19993270 | 0.78 | MAOB (0.56) | MAOBIDO1LOXL2TAAR1PYCR1 | |
| SCHEMBL1803971 | 0.76 | ESR1 (0.32) | LOXL2HRH3 | |
| SCHEMBL10337645 | 0.76 | BCL2L1 (0.55) | MAOBIDO1LOXL2BCL2L1BAD | |
| SCHEMBL12562793 | 0.76 | BCL2L1 (0.55) | MAOBIDO1LOXL2BCL2L1BAD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | claimed |
| EP-2532663-A1 | Naphthalenecarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2012-12-12 | — | — | EP | claimed |
| EP-4210706-A1 | METHODS FOR TREATING METASTASIS WITH CATHEPSIN C INHIBITORS | Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences (CN) | 2023-07-19 | — | — | EP | disclosed |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2017-06-22 | — | — | US | disclosed |
| CN-103874742-B | Carbazolocarbazole-bis (dicarboximides) and their use as semiconductors | 巴斯夫欧洲公司 | 2016-08-17 | — | — | CN | disclosed |
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | disclosed |
| CN-104919613-A | Delta-olefin oligomers and polymers and their use as hole-conducting materials | BASF SE | 2015-09-16 | — | — | CN | disclosed |
| US-20150179954-A1 | SUBSTITUTED TERRYLENE AND QUATERRYLENE DERIVATES AND USE AS SEMICONDUCTORS THEREOF | BASF SE (DE) | 2015-06-25 | — | — | US | disclosed |
| US-20140155603-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2014-06-05 | — | — | US | disclosed |
| US-8674104-B2 | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof | BASF SE (DE) | 2014-03-18 | — | — | US | disclosed |
| US-8592806-B2 | Quinone compounds as dopants in organic electronics | NOVALED AG (DE) | 2013-11-26 | — | — | US | disclosed |
| US-20110308592-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2011-08-25 | — | — | US | disclosed |
| WO-2011101810-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2011-08-25 | — | — | WO | disclosed |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| CN-101485007-A | Method for producing organic field-effect transistors | BASF SE (DE) | 2009-07-15 | — | — | CN | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| EP-1966206-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007074137-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | ICMT, EPCAM, INF2 | MAOB 3843/4885IDO1 97/4885LOXL2 1977/4885 |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | NR0B1, NR0B2, RXRB | MAOB 1320/4885IDO1 2901/4885LOXL2 2058/4885 |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO2B1, SLC43A3 | MAOB 967/4885IDO1 2877/4885LOXL2 2869/4885 |
| US-20110308592-A1 | USE OF SUBSTITUTED PERYLENES IN ORGANIC SOLAR CELLS | PPOX, JUP, CRY2 | MAOB 3503/4885IDO1 2279/4885LOXL2 1337/4885 |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | ADSL, ALAD, EED | MAOB 3091/4885IDO1 601/4885LOXL2 3780/4885 |
| US-20150179954-A1 | SUBSTITUTED TERRYLENE AND QUATERRYLENE DERIVATES AND USE AS SEMICONDUCTORS THEREOF | TST, CD99, TPST2 | MAOB 446/4885IDO1 293/4885LOXL2 1928/4885 |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | FXR2, FXR1, FTO | MAOB 1895/4885IDO1 1868/4885LOXL2 3175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.